Merck & Co., Inc. (MRK) stock

MRKNYSEPharmaceutical PreparationsFiscal year ends December 31

Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 4, 2026Score 10/30106% above fair value

$146.95−0.23 (-0.16%)

Close on Nov 12, 2026Market cap $362.55BP/E 151.5Yield 2.23%

Merck statistics

101 measures from SEC filings and the closing price. Hover a name for the formula; the last column is the median of companies in the same industry group.

Important dates

Next earnings: Feb 2, 2027 (estimated, before the open)
Last ex-dividend date: Sep 15, 2026
Fundamentals through: Sep 30, 2026
Share price as of: Nov 12, 2026

Valuation ratiosIndustry

Market Cap: $362.55B; $272.32M
Enterprise Value: $406.73B; $146.23M
PE Ratio: 151.50; 25.11
PS Ratio: 5.38; 3.66
PB Ratio: 8.08; 2.00
P/FCF Ratio: 24.59; 17.86
P/OCF Ratio: 19.38; 12.99

Enterprise valuationIndustry

EV / Sales: 6.04; 2.57
EV / FCF: 27.58; 22.27

Share statisticsIndustry

Shares Outstanding: 2.47B; 58M
Shares Change (YoY): -1.70%; 10.8%
Float: 2.47B; 49M
Shares Held by Insiders: 0.05%; 11.7%
Shares Held by Institutions: 80.3%; 56.4%

Short sellingIndustry

Short Interest: 27M; –
Short Interest Change: -0.82%; -0.80%
Short % of Float: 1.08%; 9.01%
Short % of Shares Outstanding: 1.08%; 6.30%
Days to Cover: 2.36; 5.15

Stock price statisticsIndustry

52-Week High: $156.92; –
52-Week Low: $90.90; –
20-Day Moving Average: $146.37; –
50-Day Moving Average: $146.22; –
200-Day Moving Average: $128.45; –
Average True Range (14): $4.26; –
Price Change (1 Week): 0.01%; -1.15%
Price Change (1 Month): -0.28%; -4.87%
Price Change (3 Months): 8.18%; -21.0%
Price Change (6 Months): 29.6%; -20.6%
Price Change (YTD): 39.6%; -23.6%
Price Change (1 Year): 61.6%; -22.4%
Price Change (3 Years): 43.8%; -29.5%
Price Change (5 Years): 74.9%; -77.9%
Price Change (10 Years): 131.3%; -65.4%
Average Volume (10 Days): 9M; –
Average Volume (20 Days): 10M; –
Average Volume (90 Days): 10M; –
Relative Volume: 0.62; 0.70
Relative Strength Index (14): 51.2; 43.4
Volatility (1 Year): 29.9%; 80.1%
Beta (5 Years): 0.22; 1.07

MarginsIndustry

Gross Margin: 71.8%; 53.1%
Pretax Margin: 7.07%; -11.6%
Profit Margin: 3.64%; -31.6%
FCF Margin: 21.9%; -9.56%

Returns on capitalIndustry

Return on Equity (ROE): 5.07%; -49.9%
Return on Assets (ROA): 1.87%; -40.6%

Financial positionIndustry

Current Ratio: 1.35; 3.30
Quick Ratio: 0.78; 2.39
Debt / Equity: 1.20; 0.49
Debt / FCF: 3.65; 4.65

GrowthIndustry

Revenue Growth (YoY): 4.89%; 6.82%
Net Income Growth (YoY): -87.1%; -14.4%
EPS Growth (YoY): -87.2%; -12.3%
FCF Growth (YoY): 13.0%; 6.85%
Revenue Growth (3Y CAGR): 3.12%; 2.25%
Revenue Growth (5Y CAGR): 9.38%; 6.41%
EPS Growth (3Y CAGR): 8.43%; 1.30%
EPS Growth (5Y CAGR): 21.2%; 3.78%

EfficiencyIndustry

Asset Turnover: 0.51; 0.40
Inventory Turnover: 3.02; 2.73
Revenue Per Employee: $898.37K; $429.29K
Profits Per Employee: $32.71K; -$689.41K
Employee Count: 75,000; 74
WACC: 7.05%; 10.2%

Income statement (TTM)Industry

Revenue: $67.38B; $66.37M
Gross Profit: $48.35B; $120.78M
Pretax Income: $4.76B; -$12.95M
Net Income: $2.45B; -$22.35M
EPS (Diluted): $0.97; -$0.76

Balance sheetIndustry

Cash & Short-Term Investments: $9.65B; $68.68M
Total Debt: $53.78B; $116.91M
Net Cash (Debt): -$44.13B; $17.76M
Net Cash Per Share: -$17.89; $0.80
Equity (Book Value): $44.89B; $53.89M
Book Value Per Share: $18.20; $1.50
Tangible Book Value: -$1.53B; $27.13M
Working Capital: $10.14B; $79.99M

Cash flow (TTM)Industry

Operating Cash Flow: $18.70B; -$12.38M
Capital Expenditures: -$3.96B; -$1.00M
Free Cash Flow: $14.75B; -$18.21M
FCF Per Share: $5.98; -$0.42

Dividends and yieldsIndustry

Earnings Yield: 0.68%; -21.8%
FCF Yield: 4.07%; -9.44%
Dividend Yield: 2.23%; 1.88%
Buyback Yield: 0.98%; -0.76%
Shareholder Yield: 3.21%; 0.00%
Dividend Per Share: $3.28; $0.83
Dividend Growth (YoY): 5.13%; 2.37%
Years of Dividend Growth: 15; 0
Payout Ratio: 341.1%; 55.4%
FCF Payout Ratio: 56.7%; 43.7%

Taxes and interestIndustry

Interest Expense: $1.96B; $2.90M
Income Tax: $2.31B; $73.00K
Effective Tax Rate: 48.6%; 20.9%

Scores and fair valueIndustry

Graham Number: $19.93; $19.34
Graham Upside: -86.4%; -46.6%
Altman Z-Score: 3.77; 0.23
Piotroski F-Score: 4; 4
Lynch Fair Value: $20.60; –
Lynch Upside: -86.0%; -28.9%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 12, 2026. The S&P 500 is measured by the SPY fund.

Period	MRK	S&P 500	Difference	MRK per year	S&P 500 per year
1 month	+1.0%	-2.7%	+3.7 pts
3 months	+11.2%	-1.7%	+13.0 pts
Year to date	+42.5%	+11.9%	+30.6 pts
1 year	+65.4%	+12.0%	+53.4 pts
3 years	+58.8%	+78.2%	−19.4 pts	+16.7%	+21.2%
5 years	+103.9%	+73.2%	+30.6 pts	+15.3%	+11.6%
10 years	+226.8%	+309.6%	−82.8 pts	+12.6%	+15.1%

Short interest

Shares sold short and not yet covered, reported by brokers to FINRA twice a month. Latest settlement date Oct 30, 2026.

27M MRK shares were sold short on Oct 30, 2026, down 0.8% from the previous report, or 1.08% of the shares available to trade. At recent volumes it would take 2.4 days to buy them back. Over the last 20 sessions, 37.6% of the volume reported to FINRA was short selling.

Settlement date	Shares short	Change	Avg. daily volume	Days to cover
Oct 30, 2026	26,604,245	-0.8%	11,292,813	2.4
Oct 15, 2026	26,825,098	-5.1%	9,018,768	3.0
Sep 30, 2026	28,271,750	-17.9%	11,188,097	2.5
Sep 15, 2026	34,430,712	+13.7%	8,139,823	4.2
Aug 31, 2026	30,287,347	+23.6%	13,556,043	2.2
Aug 14, 2026	24,506,520	-13.3%	8,643,326	2.8
Jul 31, 2026	28,281,375	-3.7%	8,695,853	3.3
Jul 15, 2026	29,359,028	-6.4%	8,575,599	3.4
Jun 30, 2026	31,381,267	+3.7%	13,647,853	2.3
Jun 15, 2026	30,267,292	-0.9%	11,784,643	2.6
May 29, 2026	30,545,853	+5.1%	9,991,704	3.1
May 15, 2026	29,060,187	+10.9%	8,011,358	3.6